Cargando…
Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common non-skin cancer with a tobacco consumption and infection with high-risk human papillomavirus (HPV) being major risk factors. Despite advances in numerous therapy modalities, survival rates for HNSCC have not improved considerably...
Autores principales: | Goel, Bharat, Tiwari, Anoop Kumar, Pandey, Rajeev Kumar, Singh, Akhand Pratap, Kumar, Sujeet, Sinha, Abhishek, Jain, Shreyans K., Khattri, Arun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046875/ https://www.ncbi.nlm.nih.gov/pubmed/35460943 http://dx.doi.org/10.1016/j.tranon.2022.101426 |
Ejemplares similares
-
Low expression of TMPRSS2–a SARS-CoV-2 internalization protease–associates with basal subtype of head and neck squamous cell carcinoma
por: Tiwari, Jayesh, et al.
Publicado: (2022) -
Identification and Evaluation of Apoptosis-Inducing
Activity of Ipomone from Ipomoea nil: A Novel, Unusual Bicyclo-[3.2.1] Octanone Containing Gibberic Acid
Diterpenoid
por: Goel, Bharat, et al.
Publicado: (2021) -
Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma
por: Nema, Rajeev, et al.
Publicado: (2016) -
Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor
por: Goel, Arun Kumar, et al.
Publicado: (2009) -
An update on angiogenesis targeting in head and neck squamous cell carcinoma
por: Micaily, Ida, et al.
Publicado: (2020)